DURECT Corp (NASDAQ:DRRX)
CAPS Rating:
The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.
RSS Headlines
Fool UK
Recs
Don't miss out on this potential Windfall!!! Give it a bit of time to make some great gains!!!